ArticleJournal of thoracic disease2025
Safety, efficacy, and postoperative pulmonary function recovery of uniportal and multiportal thoracoscopic lung segmentectomy.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung diseases often require surgical intervention for effective management, and with the evolution of thoracoscopic techniques, minimally invasive options like single-port video-assisted thoracoscopic surgery (VATS) have gained prominence over traditional open surgery due to their reduced invasiveness and improved outcomes. Despite its promising benefits, single-port VATS still encounters challenges that demand further investigation to optimize its clinical application. Therefore, this study aimed to compare the safety, efficacy, and postoperative lung function recovery between single-port and multiport thoracoscopic lung segmentectomy. Methods: Clinical data of a total of 105 patients with lung diseases admitted to our hospital (January 2021 to December 2022) were retrospectively analyzed. Based on different surgical approaches, patients were divided into single-port (single-port thoracoscopic lung segmentectomy, n=82) and the multiport (multiport thoracoscopic lung segmentectomy, n=23) groups. Surgical time, intraoperative blood loss, conversion to open surgery rate, length of hospital stays, hospitalization costs, complication and reoperation rates, Visual Analog Scale (VAS) scores, forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), FEV1/FVC ratio, and carbon monoxide diffusion capacity (DLCO) were compared between the two groups. Results: There were no significant differences in surgical time, conversion to open surgery rate, and reoperation rates between the two groups (P>0.05). The single-port group exhibited lower intraoperative blood loss than the multiport group (P<0.05). The length of hospital stays, hospitalization costs, short-term and long-term complication rates were lower in the single-port group compared to the multiport group (P<0.05). Preoperative VAS scores did not differ significantly between the groups (P>0.05), but the VAS scores at 1 and 3 days postoperatively were lower in the single-port group than in the multiport group (P<0.05). Preoperative FVC, FEV1, FEV1/FVC ratio, and DLCO did not significantly differ between the groups (P>0.05); however, at 1 and 3 months postoperatively, FVC, FEV1, FEV1/FVC ratio, and DLCO were superior in the single-port group compared to the multiport group (P<0.05). Conclusions: In comparison with multiport VATS, single-port VATS demonstrates higher efficacy and safety and promotes better postoperative lung function recovery, and reduces postoperative pain, surgical time, incision length, intraoperative bleeding, length of hospital stay, and hospitalization costs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.